PDF (4,3 MB) - Úrad priemyselného vlastníctva SR

50
VESTNÍK ÚRADU PRIEMYSELNÉHO VLASTNÍCTVA SR 3 - 2008 - SK (preklady patentov)
8 (51) C07D 295/00, C07D 213/00, C07D 333/00,
A61K 31/495, A61P 25/00, A61P 3/00, A61P 1/00
(11) E 2774
(96) 06290494.1, 29.3.2006
(97) 1707564, 12.9.2007
(24) 12.9.2007
(31) 0503071
(32) 30.3.2005
(33) FR
(73) Les Laboratoires Servier, Courbevoie Cedex, FR;
(72) De Nanteuil Guillaume, Suresnes, FR; Portevin
Bernard, Elancourt, FR; Gloanec Philippe, Marly-Le-Roi,
FR; Millan Mark, Le Pecq, FR; Ortuno
Jean-Claude, Bois d'Arcy, FR; Mannoury La
Cour Clotilde, Paris, FR; Gobert Alain, Rueil-
Malmaison, FR;
(74) ROTT, RŮŽIČKA & GUTTMANN, v. o. s.,
Bratislava, SK;
(54) Indalyn-piperazínové deriváty, spôsob ich prípravy
a farmaceutické kompozície s ich obsahom
8 (51) C07D 305/00
(11) E 2754
(96) 04016493.1, 13.7.2004
(97) 1616868, 12.9.2007
(24) 12.9.2007
(73) INDENA S.p.A., Milano, IT;
(72) Gabetta Bruno, Milano, IT; Zini Gianfranco, Milano,
IT;
(74) Majlingová Marta, Ing., Bratislava, SK;
(54) Spôsob získavania paklitaxelu z Taxus rastlín
8 (51) C07D 309/00
(11) E 2764
(96) 05740374.3, 21.4.2005
(97) 1758875, 3.10.2007
(24) 3.10.2007
(31) 04090157, 565849 P
(32) 22.4.2004, 28.4.2004
(33) EP, US
(73) Bayer Schering Pharma Aktiengesellschaft, Berlin,
DE;
(72) PLATZEK Johannes, Berlin, DE; PETROV Orlin,
Berlin, DE; WILLUHN Marc, c/o Zimmer, Düsseldorf,
DE; GRASKE Klaus-Dieter, Berlin, DE;
SKUBALLA Werner, Berlin, DE;
(74) Čechvalová Dagmar, Bratislava, SK;
(86) PCT/EP2005/004492
(87) WO 2005/101950
(54) Chirálne deriváty heptínu na prípravu epotilónov
a spôsob ich prípravy
8 (51) C07D 333/00, C07D 409/00, A61K 31/4427,
A61P 29/00
(11) E 2737
(96) 04701632.4, 13.1.2004
(97) 1583756, 3.10.2007
(24) 3.10.2007
(31) 0300091
(32) 15.1.2003
(33) SE
(73) AstraZeneca AB, Södertälje, SE;
(72) MORLEY Andrew David, AstraZeneca R & D
Alderley, Macclesfield, Cheshire, GB; POYSER
Jeffrey P., AstraZeneca R & D Alderley, Macclesfield,
Cheshire, GB;
(74) Čechvalová Dagmar, Bratislava, SK;
(86) PCT/GB2004/000106
(87) WO 2004/063185
(54) Tiofénové karboxamidy ako inhibítory enzýmu
IKK-2
8 (51) C07D 401/00, C07D 403/00, C07D 407/00,
C07D 409/00, C07D 413/00, A61K 31/4196,
A61K 31/4245, A61P 3/00
(11) E 2830
(96) 03814074.5, 16.12.2003
(97) 1581515, 10.10.2007
(24) 10.10.2007
(31) 435074 P, 458592 P, 503410 P
(32) 20.12.2002, 28.3.2003, 16.9.2003
(33) US, US, US
(73) Merck & Co., Inc., Rahway, New Jersey, US;
(72) WADDELL Sherman T., Rahway, NJ, US; SAN-
TORELLI Gina M., Rahway, NJ, US; MALETIC
Milana M., Rahway, NJ, US; LEEMAN Aaron
H., Rahway, NJ, US; GU Xin, Rahway, NJ, US;
GRAHAM Donald W., Rahway, NJ, US; BAL-
KOVEC James M., Rahway, NJ, US; ASTER
Susan D., Rahway, NJ, US;
(74) Majlingová Marta, Ing., Bratislava, SK;
(86) PCT/US2003/040127
(87) WO 2004/058741
(54) Triazolové deriváty ako inhibítory 11-beta-
-hydroxysteroid dehydrogenázy-1
8 (51) C07D 403/00, C07D 401/00, C07D 417/00,
A61K 31/427, A61P 3/00
(11) E 2846
(96) 03750648.2, 26.9.2003
(97) 1549638, 3.10.2007
(24) 3.10.2007
(31) 415737 P
(32) 3.10.2002
(33) US
(73) F. HOFFMANN-LA ROCHE AG, Basel, CH;
(72) CORBETT Wendy Lea, Randolph, US;
(74) Bušová Eva, JUDr., Bratislava, SK;
(86) PCT/EP2003/010776
(87) WO 2004/031179
(54) Indol-2-karboxamidy ako aktivátory glukokinázy
(GK)
8 (51) C07D 405/00, A61K 31/445
(11) E 2760
(96) 04736513.5, 10.6.2004
(97) 1638959, 19.9.2007
(24) 19.9.2007
(31) PCT/EP03/50237
(32) 19.6.2003
(33) WO
(73) Janssen Pharmaceutica N.V., Beerse, BE;
(72) BOSMANS Jean-Paul René Marie André, Beerse,
BE; GIJSEN Henricus Jacobus Maria, Beerse,
BE; MEVELLEC Laurence Anne, Issy-les-Moulineaux
Cedex 9, FR;